James S. Shapiro

James Shapiro, M.D., Ph.D. is Professor of Surgery, Medicine and Surgical Oncology, and Director of the Clinical Islet and Living Donor Liver Transplant Programs at the University of Alberta in Edmonton, Canada. He directs one of the leading clinical islet transplant programs worldwide with hundreds of patients treated and was the lead investigator of the team that developed the “Edmonton Protocol,” the first trial to achieve consistent 100% insulin independence in islet-alone transplant recipients with type 1 diabetes. Dr. Shapiro subsequently led the trial which replicated these findings in nine international centers. He has an active experimental laboratory working on improving long term survival of transplanted islets and in immunomodulation of transplanted tissues. Dr. Shapiro is fellow of the Royal Society of Canada and has received several prestigious awards, including the Hunterian Medal from the Royal College of Surgeons of England, the Paul E. Lacy Gold Medal, the Gold Medal in Surgery from the Royal College of Physicians and Surgeons of Canada, the Governor General’s Gold Medal, the Queen’s Jubilee Medal, the Meritorious Service Medal. He obtained his M.D. at the University of Newcastle-upon-Tyne and trained in surgery at the University of Bristol, UK.